Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
342 participants
INTERVENTIONAL
2003-03-31
2005-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Myfortic
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Recipients of first, heart-beating cadaveric, living unrelated or living related non-HLA identical donor kidney transplant, treated with Simulect® and Neoral® as primary immunosuppression.
Exclusion Criteria
* Kidneys from non-heart beating donors or HLA identical living related donors.
* ABO incompatibility against the donor.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Novartis
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Novartis
Role: STUDY_DIRECTOR
Novartis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCSF Kidney Transplant Service
San Francisco, California, United States
Livelink, Inc.
Tampa, Florida, United States
Loyola Medical Center
Maywood, Illinois, United States
Indiana U. Medical Center
Indianapolis, Indiana, United States
University of Michigan Health System
Ann Arbor, Michigan, United States
University Hospitals of Cleveland, Division of Nephrology
Cleveland, Ohio, United States
Ohio State University Medical Center
Columbus, Ohio, United States
Legacy Research & Technology Ctr.
Portland, Oregon, United States
U. of Wisconsin Hospital Clinics
Madison, Wisconsin, United States
Crai Norte
San Martín, Buenos Aires, Argentina
Hospital Cordoba
Córdoba, Córdoba Province, Argentina
Unidad de Transplante Velez Sarsfield
Córdoba, Córdoba Province, Argentina
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
The Queen Elizabeth Hospital
Woodville, South Australia, Australia
Monash Medical Centre
Clayton, Victoria, Australia
Royal Melbourne Hospital
Parkville, Victoria, Australia
Hospital das Clinicas - UNICAMP
Campinas, São Paulo, Brazil
Hipertensao Hospital do Rim e Hipertensao
São Paulo, São Paulo, Brazil
Foothills Medical Center
Calgary, Alberta, Canada
University of Alberta Hospital
Edmonton, Alberta, Canada
Queen II Health and Science Center
Halifax, Nova Scotia, Canada
St. Michael's Hospital
Toronto, Ontario, Canada
University Health Network, The Toronto Hospital
Toronto, Ontario, Canada
McGill University Health Centre
Montreal, Quebec, Canada
Royal University Hospital
Saskatoon, Saskatchewan, Canada
Staedt. Krankenhaus Koeln-Merheim
Cologne, , Germany
Klinikum der Johann Wolfgang Geothe-Universitaet
Frankfurt am Main, , Germany
Ospedale Consorziale e policlinico-Universita degli Studi
Bari, BA, Italy
Hospital Kuala Lumpur
Kuala Lumpur, , Malaysia
Auckland Hospital
Auckland, Grafton, New Zealand
Singapore General Hospital
Singapore, , Singapore
Hospital Clinico San Carlos
Madrid, Madrid, Spain
Hospital Central de Asturias
Oviedo, Oviedo, Spain
Hospital de Bellvitge
L'Hospitalet de Llobregat, , Spain
Chang-Gung Memorial Hospital-Linko
Taoyuan District, Lin-Ko, Taiwan
Taipei Veterans General Hospital
Taipei, ROC, Taiwan
National Taiwan University Hospital
Taipei, , Taiwan
Queen Elizabeth Medical Centre
Edgbaston, Birmingham, United Kingdom
University Hospital of Wales
Heathpark, Cardiff, United Kingdom
Walsgrave Hospital NHS Trust
Walsgrave on Sowe, Coventry, United Kingdom
Freeman Hospital
High Heaton, Newcastle Upon Tyne, United Kingdom
Guy's Hospital
London, , United Kingdom
Nottingham City Hospital
Nottingham, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CERL080A2404
Identifier Type: -
Identifier Source: org_study_id